Vera Therapeutics, Inc.
VERA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831828
In the last 90 days, Vera Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Vera Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 214
- +44 vs. Q3 2025
- Shares held
- 74.0M
- +9.28M (+14.3%) vs. Q3 2025
- Total value
- $3.75B
- +$1.87B (+99.3%) vs. Q3 2025
- New holders
- 62
- 79 more added
- Sold out
- 18
- 59 more reduced
6 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VERA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 219 | $3.34B |
| Q1 2026 | 229 | $2.92B |
| Q4 2025 | 214 | $3.75B |
| Q3 2025 | 176 | $1.89B |
| Q2 2025 | 172 | $1.51B |
| Q1 2025 | 179 | $1.52B |
| Q4 2024 | 178 | $2.66B |
| Q3 2024 | 173 | $2.37B |
| Q2 2024 | 171 | $1.92B |
| Q1 2024 | 159 | $2.21B |
| Q4 2023 | 95 | $637.2M |
| Q3 2023 | 84 | $538.2M |
| Q2 2023 | 76 | $611.9M |
| Q1 2023 | 70 | $289.7M |
| Q4 2022 | 59 | $412.8M |
| Q3 2022 | 55 | $459.0M |
| Q2 2022 | 51 | $277.6M |
| Q1 2022 | 50 | $468.9M |
| Q4 2021 | 37 | $374.9M |
| Q3 2021 | 31 | $252.4M |
| Q2 2021 | 22 | $186.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Vera Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bellevue Group AG | 1,698,152 | $86.0M | 1.63% | +1,698,152 | New |
| Point72 Asset Management, L.P. | 1,738,385 | $88.0M | 0.14% | +466,358+36.7% | Added |
| Integral Health Asset Management, LLC | 1,800,000 | $91.2M | 4.62% | +100,000+5.9% | Added |
| State Street Corp | 2,676,600 | $135.5M | 0.00% | +343,017+14.7% | Added |
| Sofinnova Investments, Inc. | 2,793,987 | $141.5M | 6.10% | 00.0% | Unchanged |
| Deep Track Capital, LP | 2,821,135 | $142.9M | 3.26% | +2,821,135 | New |
| FMR LLC | 2,885,853 | $146.1M | 0.01% | +42,722+1.5% | Added |
| Eversept Partners, LP | 3,072,304 | $155.6M | 8.72% | +264,468+9.4% | Added |
| Kynam Capital Management, LP | 3,433,051 | $173.8M | 11.32% | −594,749−14.8% | Reduced |
| Vanguard Group Inc | 3,570,401 | $180.8M | 0.00% | +379,748+11.9% | Added |
| Deerfield Management Company, L.P. (Series C) | 4,059,695 | $205.6M | 2.64% | +418,538+11.5% | Added |
| BlackRock, Inc. | 4,825,519 | $244.4M | 0.00% | +578,329+13.6% | Added |
| Price T Rowe Associates Inc | 5,461,976 | $276.6M | 0.03% | +1,795,537+49.0% | Added |
| Avoro Capital Advisors LLC | 5,888,888 | $298.2M | 2.93% | −321,112−5.2% | Reduced |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −1,350,000−100.0% | Sold out |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −563,075−100.0% | Sold out |
| Capricorn Fund Managers Ltd | 0 | $0 | 0.00% | −450,700−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −440,591−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −297,017−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −91,189−100.0% | Sold out |
| SummitTX Capital, L.P. | 0 | $0 | 0.00% | −87,653−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −40,877−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −40,851−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −22,539−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −22,138−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −20,786−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −13,042−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −11,983−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −5,225−100.0% | Sold out |
| Fifth Third Bancorp | 0 | $0 | 0.00% | −4,330−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| AXA Investment Managers S.A. | – | – | – | – | Not filed |
| Cubist Systematic Strategies, LLC | – | – | – | – | Not filed |
| Yale University | – | – | – | – | Not filed |
| Corton Capital Inc. | – | – | – | – | Not filed |
| Point72 (DIFC) Ltd | – | – | – | – | Not filed |
| Point72 Europe (London) LLP | – | – | – | – | Not filed |